Keck USC 9th Annual Southern California Kidney Symposium 2025

The Keck USC 9th Annual Southern California Kidney Symposium 2025 is a comprehensive, academically rigorous nephrology education program focused on biologics and novel therapeutics for kidney diseases. Organized by Keck School of Medicine of USC, this flagship annual symposium brings together leading experts from USC and major U.S. academic institutions to present the latest clinical and translational advances in renal medicine.
Held on Friday, June 6, 2025, at the Aresty Conference Center, USC Health Sciences Campus (Los Angeles, CA), this program is now available as a complete on-demand learning package, allowing clinicians worldwide to access cutting-edge content at their convenience.
The course includes 11 full-length video lectures, 11 corresponding audio sessions, subtitle (VTT) files for each lecture, and 2 supporting PDF resources (total size: 4.32 GB). It is ideal for clinicians who want practical, evidence-based updates that can be directly translated into patient care.

🔹 Program Focus

The 2025 symposium theme, “Updates on Biologics and Novel Therapeutics for Kidney Diseases,” addresses rapidly evolving treatment strategies across:

• Hypertension and resistant hypertension

• Advanced CKD and ESKD

• Glomerular diseases and immune-mediated nephropathies

• Onco-nephrology and transplant medicine

Presentations integrate new molecular targets, emerging biologics, and innovative therapeutic mechanisms, with a strong emphasis on clinical applicability.

🔹 Learning Objectives

By the end of this course, participants will be able to:

• Evaluate new drug therapies for hypertension, hyperphosphatemia, and anemia in CKD and compare them with established treatments

• Compare emerging therapies for IgA nephropathy, including benefits and limitations

• Outline new diagnostic and therapeutic strategies for membranous nephropathy

• Summarize novel treatment targets for lupus nephritis and C3 glomerulopathy

• Assess APOL1-mediated CKD therapies and underlying mechanisms

• Recognize renal toxicities of newer targeted cancer therapies

• Analyze treatment strategies for antibody-mediated rejection and disease recurrence in kidney transplant patients

🔹 Who Should Use This Course

• Nephrologists & Kidney Specialists managing CKD, glomerular disease, and transplant patients

• Internists & Hospitalists co-managing renal and multisystem disease

• Advanced Practice Providers (NPs, PAs) in nephrology or internal medicine

• Researchers & Translational Scientists focused on renal biologics and therapeutics

• Residents & Fellows preparing for boards or advancing subspecialty expertise

🔹 Topics Covered

1. Microangiopathic Hemolytic Anemia: TTP & Atypical HUS

2. Novel Therapies in APOL1-Mediated Kidney Disease

3. Endothelin Inhibition in Resistant Hypertension

4. New Treatments for Hyperphosphatemia in ESKD

5. HIF Activation in CKD-Related Anemia

6. New Therapies for Glomerular Diseases & IgA Nephropathy

7. Emerging Strategies for Membranous Nephropathy

8. Expanded Targets for Lupus Nephritis

9. Genetic Factors & Therapies in C3 Glomerulopathy

10. Immune Checkpoint Inhibitor–Induced AKI

11. Biologics for Antibody-Mediated Rejection in Kidney Transplantation